The Oncosearch | Oncotarget

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Tasaduq H. Wani, Sreeraj Surendran, Vishnu S. Mishra, Jaya Chaturvedi, Goutam Chowdhury, Anindita Chakrabarty

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33589-33600

Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction Research Paper

Zain Khurshid, Hojjat Ahmadzadehfar, Florian C. Gaertner, LÃ¡szlÃ³ Papp, Norbert ZsÃ³ter, Markus Essler, Ralph A. Bundschuh

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33312-33321

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis) Research Paper

Takao Ukaji, Ai Takemoto, Ryohei Katayama, Kengo Takeuchi, Naoya Fujita

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33322-33336

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Chie Kikutake, Minako Yoshihara, Tetsuya Sato, Daisuke Saito, Mikita Suyama

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33337-33347

Loss of Gadd45b accelerates BCR-ABL-driven CML Research Paper

Xiaojin Sha, Barbara Hoffman, Dan A. Liebermann

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33360-33367

Cancer stem cells in progression of colorectal cancer Review

Yujuan Zhou, Longzheng Xia, Heran Wang, Linda Oyang, Min Su, Qiang Liu, Jingguan Lin, Shiming Tan, Yutong Tian, Qianjin Liao, Deliang Cao

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33403-33415

Glioblastoma in the setting of prior lower grade gliomas â€“ insights from SEER database Research Paper

Ha Son Nguyen, Benjamin Best, Ninh B. Doan, Michael Gelsomino, Saman Shabani, Ahmed J. Awad, Mayank Kaushal, Martin M. Mortazavi

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33271-33277

Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel Research Paper

Shengwen Calvin Li, Andres Stucky, Xuelian Chen, Mustafa H. Kabeer, William G. Loudon, Ashley S. Plant, Lilibeth Torno, Chaitali S. Nangia, Jin Cai, Gang Zhang, Jiang F. Zhong

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33290-33301

The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7 Research Paper

Dominique Thuringer, Gaetan Chanteloup, Pascale Winckler, Carmen Garrido

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33302-33311

Modeling and antitumor studies of a modified Lâ€“penetratin peptide targeting E2F in lung cancer and prostate cancer Priority Research Paper

Tazeem Shaik, Gulam M, Rather, Nitu Bansal, Tamara Minko, Olga Garbuzenko, Zoltan Szekely, Emine E. Abali, Debabrata Banerjee, John E. Kerrigan, Kathleen W. Scotto, Joseph R. Bertino

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33249-33257

N-(2Â´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells Research Paper

Arturo Contis-Montes de Oca, EstefanÃa Rodarte-Valle, Martha Cecilia Rosales-HernÃ¡ndez, Edgar Abarca-Rojano, SaÃºl Rojas-HernÃ¡ndez, Manuel Jonathan Fragoso-VÃ¡zquez, Jessica Elena Mendieta-Wejebe, Ana MarÃa Correa-Basurto, Ismael VÃ¡zquez-Moctezuma, JosÃ© Correa-Basurto

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33368-33381

Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib Research Paper

James A. MacLeod, Yan Gao, Christine Hall, William J. Muller, Taranjit S. Gujral, Peter A. Greer

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33382-33395

Meta-analysis of the likelihood of FOXC2 expression in early- and late-stage tumors Meta-Analysis

Tsutomu Kume, Tarek Shackour

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33396-33402

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth Research Paper

Janet K. Parrish, Tyler S. McCann, Marybeth Sechler, Lays M. Sobral, Wen Hua Ren, Kenneth L. Jones, Aik Choon Tan, Paul Jedlicka

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33110-33123

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth Research Paper

Nagindra Prashad

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33186-33201

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells Research Paper

Manoranjan Sahoo, Gajendra K. Katara, Mahmood Y. Bilal, Safaa A. Ibrahim, Arpita Kulshrestha, Sara Fleetwood, Kimiko Suzue, Kenneth D. Beaman

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33215-33231

Distinct urinary glycoprotein signatures in prostate cancer patients Research Paper

Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa GuimarÃ£es, Daniel Quina, Willian Nahas, Veit SchwÃ¤mmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen, Giuseppe Palmisano

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33077-33097

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAGâ€™s receptor ILT2 on peripheral CD8⁺ T cells Research Paper

Francois Desgrandchamps, Joel LeMaoult, Annabelle Goujon, Adrien Riviere, Antonio Rivero-Juarez, Malika Djouadou, Amory de Gouvello, Clement Dumont, Ching-Lien Wu, Stephane Culine, Jerome Verine, Nathalie Rouas-Freiss, Christophe Hennequin, Alexandra Masson-Lecomte, Edgardo D. Carosella

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33160-33169

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

Vikas Dembla, Neeta Somaiah, Pedro Barata, Kenneth Hess, Siqing Fu, Filip Janku, Daniel D. Karp, Aung Naing, Sarina Anne Piha-Paul, Vivek Subbiah, Apostolia M. Tsimberidou, Kenna Shaw, Funda Meric-Bernstam, David S. Hong

Published Sep 4, 2018 · Vol. 9, No. 69 · pp. 33232-33243

A new drug combination significantly reduces kidney tumor progression in kidney mouse model Priority Research Paper

Sitai Liang, Tiffanie Cuellar, Maciej Nowacki, Bijaya K. Nayak, Lily Dong, Boajie Li, Kumar Sharma, Samy L. Habib

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32900-32916

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction Research Paper

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis) Research Paper

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Loss of Gadd45b accelerates BCR-ABL-driven CML Research Paper

Cancer stem cells in progression of colorectal cancer Review

Glioblastoma in the setting of prior lower grade gliomas â€“ insights from SEER database Research Paper

Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel Research Paper

The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7 Research Paper

Modeling and antitumor studies of a modified Lâ€“penetratin peptide targeting E2F in lung cancer and prostate cancer Priority Research Paper

N-(2Â´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells Research Paper

Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib Research Paper

Meta-analysis of the likelihood of FOXC2 expression in early- and late-stage tumors Meta-Analysis

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth Research Paper

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth Research Paper

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells Research Paper

Distinct urinary glycoprotein signatures in prostate cancer patients Research Paper

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAGâ€™s receptor ILT2 on peripheral CD8⁺ T cells Research Paper

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

A new drug combination significantly reduces kidney tumor progression in kidney mouse model Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction Research Paper

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis) Research Paper

Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer Research Paper

Loss of Gadd45b accelerates BCR-ABL-driven CML Research Paper

Cancer stem cells in progression of colorectal cancer Review

Glioblastoma in the setting of prior lower grade gliomas â€“ insights from SEER database Research Paper

Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel Research Paper

The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7 Research Paper

Modeling and antitumor studies of a modified Lâ€“penetratin peptide targeting E2F in lung cancer and prostate cancer Priority Research Paper

N-(2Â´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells Research Paper

Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib Research Paper

Meta-analysis of the likelihood of FOXC2 expression in early- and late-stage tumors Meta-Analysis

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth Research Paper

miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth Research Paper

Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells Research Paper

Distinct urinary glycoprotein signatures in prostate cancer patients Research Paper

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAGâ€™s receptor ILT2 on peripheral CD8+ T cells Research Paper

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic Research Paper

A new drug combination significantly reduces kidney tumor progression in kidney mouse model Priority Research Paper

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAGâ€™s receptor ILT2 on peripheral CD8⁺ T cells Research Paper